Developer of specialty pharmaceutical products intended to address unmet patient needs and rare diseases. The company develops and commercializes pharmaceutical products for the treatment of pouchitis and ulcerative colitis, enabling patients suffering from gastrointestinal diseases.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC | 21-Mar-2016 | $23.6M | 000.00 | 00000 | Completed | Generating Revenue |
4. Later Stage VC | 17-Dec-2013 | 000.00 | 000.00 | 00000 | Completed | Generating Revenue |
3. Grant | 18-Mar-2013 | 00.000 | 00.000 | Completed | Generating Revenue | |
2. Later Stage VC | 04-Apr-2012 | $1.58M | $4.97M | Completed | Generating Revenue | |
1. Later Stage VC | 17-Aug-2011 | $3.38M | $3.38M | 000.00 | Completed | Startup |
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Ordinary | 000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 0.000 | |
Hurdle | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
Ordinary | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Ordinary | 00,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
Ordinary | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Ordinary | 000,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
Ordinary | 000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 0.000 | |
Ordinary | 100,850 | $0.000709 | $20.57 | $20.57 | 1x | $20.57 | 0.34% | |
Ordinary | 1,915 | $0.000709 | $27.17 | $27.17 | 1x | $27.17 | 0.01% |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Tobias Wilson Waterworth | Founder, Chief Executive Officer & Board Member | ||
David Bennett | Chief Operating Officer |
Name | Representing | Role | Since |
---|---|---|---|
Andrew Boyce | Atlantic Healthcare | Board Member | 000 0000 |
Charles Hoare | Self | Non-Executive Director - UK | 000 0000 |
Charles Woler | Atlantic Healthcare | Board Member | 000 0000 |
Thomas Wellner | Self | Chairman and Non-Executive Director | 000 0000 |
Tobias Wilson Waterworth | Atlantic Healthcare | Founder, Chief Executive Officer & Board Member | 000 0000 |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Fullbrook Thorpe Investments | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Societe LDC | Corporation | Minority | 000 0000 | 000000 0 | |
ACF Investors | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
Finance East | Angel Group | Minority | 000 0000 | 000000 0 | |
Start Capital | Venture Capital | Minority | 000 0000 | 000000 0 |
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000000000 (00 | 01-Jul-2019 | 000000000 | Buildings and Property | 000000 00 |